Adalat retard 10 mg modified-release tablets
Last Updated on eMC 13-Jun-2017 View document | Bayer plc Contact details
Versions
- 13-Jun-2017 to Current
- 22-Aug-2016 to 13-Jun-2017
- 14-Aug-2015 to 22-Aug-2016
- 28-Jan-2014 to 14-Aug-2015
- 17-Apr-2012 to 28-Jan-2014
- 15-Feb-2012 to 17-Apr-2012
- 01-May-2009 to 15-Feb-2012
- 15-Apr-2009 to 01-May-2009
- 30-Jun-2008 to 15-Apr-2009
- 25-Oct-2006 to 30-Jun-2008
- 20-Jan-2005 to 25-Oct-2006
- 23-Jan-2004 to 20-Jan-2005
- 05-Nov-2002 to 23-Jan-2004
- 25-Sep-2001 to 05-Nov-2002
- 27-Jun-2000 to 25-Sep-2001
When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.
Updated on 13-Jun-2017 and displayed until Current
Reasons for adding or updating:
- Change to section 6 - manufacturer
- Change to section 6 - date of revision
Updated on 22-Aug-2016 and displayed until 13-Jun-2017
Reasons for adding or updating:
- Change to section 4 - possible side effects
- Change to section 6 - date of revision
Updated on 14-Aug-2015 and displayed until 22-Aug-2016
Reasons for adding or updating:
- Change to section 6 - date of revision
Updated on 28-Jan-2014 and displayed until 14-Aug-2015
Reasons for adding or updating:
- Change to section 2 - what you need to know - contraindications
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 2 - pregnancy, breast feeding and fertility
- Change to section 6 - date of revision
Updated on 17-Apr-2012 and displayed until 28-Jan-2014
Reasons for adding or updating:
- Change to date of revision
Updated on 15-Feb-2012 and displayed until 17-Apr-2012
Reasons for adding or updating:
- Change to date of revision
- Change to side-effects
- Change to dosage and administration
Updated on 01-May-2009 and displayed until 15-Feb-2012
Reasons for adding or updating:
- Change due to user-testing of patient information
Updated on 15-Apr-2009 and displayed until 01-May-2009
Reasons for adding or updating:
- Change to name of manufacturer
Updated on 30-Jun-2008 and displayed until 15-Apr-2009
Reasons for adding or updating:
- Change to Marketing Authorisation Holder
Updated on 25-Oct-2006 and displayed until 30-Jun-2008
Reasons for adding or updating:
- Change to instructions about overdose
- Change to date of revision
Updated on 20-Jan-2005 and displayed until 25-Oct-2006
Reasons for adding or updating:
- Change of manufacturer
Updated on 23-Jan-2004 and displayed until 20-Jan-2005
Reasons for adding or updating:
- Update to PIL
Updated on 05-Nov-2002 and displayed until 23-Jan-2004
Reasons for adding or updating:
- Update to PIL
Updated on 25-Sep-2001 and displayed until 05-Nov-2002
Reasons for adding or updating:
- Update to PIL
Updated on 27-Jun-2000 and displayed until 25-Sep-2001
Reasons for adding or updating:
- No reasons supplied
Bayer plc
Bayer House, Strawberry Hill, Newbury, Berkshire, RG14 1JA
+44 (0)1635 563 393
+44 (0)1635 563 000
Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Active ingredients
Legal categories
This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue